These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 8350961)

  • 1. Expression of p43 associated placental isoferritin (PLF) correlates inversely with cell growth in breast cancer cell lines MCF-7 and T47-D.
    Reinerová MH; Rosen HR; Veselovská Z; Stierer M; Svec J
    Neoplasma; 1993; 40(3):147-51. PubMed ID: 8350961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placental isoferritin associated p43 antigen correlates with features of high differentiation in breast cancer.
    Rosen HR; Moroz C; Reiner A; Reinerova M; Stierer M; Svec J; Schemper M; Jakesz R
    Breast Cancer Res Treat; 1992; 24(1):17-26. PubMed ID: 1463868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive activity of lymphocyte mitogenesis by breast cancer-associated p43.
    Reinerová M; Veselovská Z; Ausch C; Rosen HR
    Neoplasma; 1996; 43(6):363-6. PubMed ID: 8996559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro estradiol-sensitivity characterization of the MCF-7, ZR-75, MDA-MB-231 and T47-D human breast neoplastic cell lines.
    Camby I; Kiss R
    Anticancer Res; 1993; 13(6A):2355-60. PubMed ID: 8297158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of jun gene family members by transforming growth factor alpha but not 17 beta-estradiol in human breast cancer cells.
    Davidson NE; Prestigiacomo LJ; Hahm HA
    Cancer Res; 1993 Jan; 53(2):291-7. PubMed ID: 8417822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro.
    Shamsuddin AM; Yang GY; Vucenik I
    Anticancer Res; 1996; 16(6A):3287-92. PubMed ID: 9042302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of women with early breast cancer by analysis of p43-positive lymphocytes.
    Auerbach L; Hellan M; Stierer M; Rosen AC; Ausch C; Obwegeser R; Kubista E; Wolf G; Rosen HR; Panzer S
    Br J Cancer; 1999 May; 80(5-6):874-8. PubMed ID: 10360668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can transforming growth factor-beta1 and retinoids modify the activity of estradiol and antiestrogens in MCF-7 breast cancer cells?
    Czeczuga-Semeniuk E; Anchim T; Dziecioł J; Dabrowska M; Wołczyński S
    Acta Biochim Pol; 2004; 51(3):733-45. PubMed ID: 15448735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of 17 beta-estradiol, progesterone, synthetic progestins, tibolone, and tibolone metabolites on vascular endothelial growth factor mRNA in breast cancer cells.
    Mirkin S; Wong BC; Archer DF
    Fertil Steril; 2005 Aug; 84(2):485-91. PubMed ID: 16084894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone and 5 alpha-dihydrotestosterone inhibit in vitro growth of human breast cancer cell lines.
    Ortmann J; Prifti S; Bohlmann MK; Rehberger-Schneider S; Strowitzki T; Rabe T
    Gynecol Endocrinol; 2002 Apr; 16(2):113-20. PubMed ID: 12012621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversible inhibition of proliferation of epithelial cell lines by Agaricus bisporus (edible mushroom) lectin.
    Yu L; Fernig DG; Smith JA; Milton JD; Rhodes JM
    Cancer Res; 1993 Oct; 53(19):4627-32. PubMed ID: 8402638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
    Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
    Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MUC1 expression in human breast cancer cells is altered by the factors affecting cell proliferation.
    Porowska H; Paszkiewicz-Gadek A; Wołczyński S; Gindzieński A
    Neoplasma; 2002; 49(2):104-9. PubMed ID: 12088101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of CCL5 in invasion, proliferation and proportion of CD44+/CD24- phenotype of MCF-7 cells and correlation of CCL5 and CCR5 expression with breast cancer progression.
    Zhang Y; Yao F; Yao X; Yi C; Tan C; Wei L; Sun S
    Oncol Rep; 2009 Apr; 21(4):1113-21. PubMed ID: 19288016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA; Surmacz E
    Exp Cell Res; 1997 Feb; 231(1):149-62. PubMed ID: 9056422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 13-cis retinoic acid and all-trans retinoic acid in the regulation of the proliferation and survival of human breast cancer cell line MCF-7.
    Czeczuga-Semeniuk E; Wolczyński S; Dziecioł J; Dabrowska M; Anchim T; Tomaszewska I
    Cell Mol Biol Lett; 2001; 6(4):925-39. PubMed ID: 11753438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53-dependent inhibition of progestin-induced VEGF expression in human breast cancer cells.
    Liang Y; Wu J; Stancel GM; Hyder SM
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):173-82. PubMed ID: 15860260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal.
    Lewis JS; Osipo C; Meeke K; Jordan VC
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):131-41. PubMed ID: 15862958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells.
    Gooch JL; Lee AV; Yee D
    Cancer Res; 1998 Sep; 58(18):4199-205. PubMed ID: 9751635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.